Geron Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp.

GERN 1.230

+2.5%

10:46 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Savant who wrote (2699)	8/20/2003 11:53:23 AM
From: Ron	of 3576

Geron Corp (NASDAQ:GERN) on Wednesday said it had successfully transplanted heart muscle cells derived from human embryonic stem cells into the hearts of rats and that the human cells appeared to be dividing and forming new heart tissue in the rodents. The Menlo Park, California-based biotech firm said the human heart cells were transplanted into healthy rats, but that other studies will test whether such transplanted human cells can help animals that have suffered heart attacks. "These results exemplify one of the basic advantages of using human embryonic stem cell-derived cells for tissue engineering -- namely their ability to re-create the natural developmental biology of new tissue formation," Geron Chief Executive Officer Thomas Okarma said in a statement. The company said an analysis of the mature grafted tissue indicated the researchers transplanted only human heart cells to the rats, and no other types of human tissue cells. Geron said it had presented data from its study at a meeting of the American Heart Association. NEW YORK, Aug 20 (Reuters)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next